NASDAQ · Healthcare · Biotechnology
Bio-Techne Corporation
TECH
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. CEO Kim Kelderman · Market cap $11.1B.
$71.00
+0.30 · +0.42%
52w hi $72.1652w lo $43.20
44
ROUTINE
Current InsiderScore
Corp · 90d
0
0 buys · 0 sales
Cong · 90d
1
0 buys · 1 sales
Signals ≥ 60 · 12mo
0
0 strong · 0 notable
Analyst consensus
—
—
Section 01
Recent Form 4 filings
No filings yet
No Form 4 filings on record. As the backfill progresses this will populate.
Section 02
Recent STOCK Act disclosures
4 disclosures on file
| Disclosed | Legislator | Chamber · State | Action | Range | Midpoint | Delay | Score |
|---|---|---|---|---|---|---|---|
| May 07 | April Delaney | House · MD | Sell | $1,001 - $15,000 | $8K | 29 d | 44 |
| Apr 08 | April Delaney | House · MD | Sell | $1,001 - $15,000 | $8K | 13 d | 48 |
| Mar 11 | April Delaney | House · MD | Sell | $1,001 - $15,000 | $8K | 15 d | 44 |
| Feb 03 | April Delaney | House · MD | Sell | $1,001 - $15,000 | $8K | 6 d | 51 |
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JulAugSepOctNovDecJanFebMarAprMayJun